Evaluasi Terapi Pada Pasien Hepatitis B Di Rsup Dr. Sardjito YOGYAKARTA

Chronic infection with hepatitis B virus (HBV) is a serious problem because of its spread around the world is quite high (350 million people infected with HBV). This study aims to describe fitness, therapeutic results and the effect of compliance against the results of therapy in patients with hepatitis B in the General Hospital Center (Dr) Dr. Sardjito. This study was an observational study using cross sectional design (cross-sectional). Data were collected in June-October 2015 from the medical records retrospectively. Respondents involved in this study was the patient that recorded in the patient's medical records department of Dr. Sardjito during 2012-2014. Type of data that was collected form patient are demographic data, including age, sex, data on the treatment of patients (type of drug, dosage, frequency and duration). The results of the study described in descriptive and presented in tabular form / percentage. Results of this study shows that patient recieve supportive therapy 26.88%, 3.75% antiviral therapy, and other therapies 69.37%. Suitability of antiviral therapy were given for patient was 100%, with 80.22% therapeutic efficacy.Keywords: Hepatitis B, adjusment therapy, result therapyINTISARIInfeksi kronik virus hepatitis B (HBV) merupakan masalah yang serius karena penyebarannya di seluruh dunia cukup tinggi. Sampai saat ini diperkirakan sekitar 350 juta orang terinfeksi HBV. Penelitian ini bertujuan untuk mengetahui gambaran terapi, kesesuaian, hasil terapi dan pengaruh kesesuaian terhadap hasil terapi pada pasien hepatitis B di Rumah Sakit Umum Pusat (RSUP) Dr. Sardjito Yogyakarta. Penelitian ini merupakan penelitian observasional dengan menggunakan rancangan cross sectional (potong lintang). Pengambilan data dilakukan bulan Juni-Oktober 2015 dari rekam medik secara retrospektif. Responden yang terlibat adalah pasien yang tercatat dalam rekam medik RSUP Dr. Sardjito Yogyakarta tahun 2012-2014. Data yang dikumpulkan berupa data demografi pasien, meliputi umur, jenis kelamin, data mengenai pengobatan pasien (jenis obat, dosis, frekuensi dan durasi). Hasil penelitian digambarkan secara deskriptif dan disajikan dalam bentuk tabel/persentase. Hasil gambaran terapi hepatitis B: terapi suportif 26,88%, terapi antiviral 3,75%, terapi lain-lain 69,37%. Kesesuaian terapi antiviral yang diberikan 100%, keberhasilan terapi 80,22%